HIGHLIGHTS
- who: Christopher W. Rowe from the (UNIVERSITY) have published the research work: The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis, in the Journal: (JOURNAL)
- what: These data show that proNGF is not a useful clinical biomarker of thyroid malignancies.
- how: To collect serum the authors conducted a prospective nested cohort study enrolling patients undergoing thyroid surgery or thyroid fine-needle aspiration biopsy for investigation or management of thyroid disease.
SUMMARY
At present, the diagnostic evaluation of nodular thyroid . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.